{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:06:19Z","timestamp":1789470379997,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministero dell'Istruzionedell'Universita e della Ricerca (MIUR)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejmech.2016.09.013","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T19:03:37Z","timestamp":1473447817000},"page":"840-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["[1,2]Oxazolo[5,4- e ]isoindoles as promising tubulin polymerization inhibitors"],"prefix":"10.1016","volume":"124","author":[{"given":"Virginia","family":"Span\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Pennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Parrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Montalbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Lopergolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Zuco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Cominetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolamo","family":"Cirrincione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Barraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.09.013_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/md13010460","article-title":"Synthesis and antiproliferative activity of thiazolyl-bis-pyrrolo[2,3-b]pyridines and indolyl-thiazolyl-pyrrolo[2,3-c]pyridines, nortopsentin analogues","volume":"13","author":"Carbone","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2016.09.013_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.08.003","article-title":"Pyrazolo[3,4-h]quinolines promising photosensitizing agents in the treatment of cancer","volume":"102","author":"Span\u00f2","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib3","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1021\/jm501244f","article-title":"11H-Pyrido[3\u2032,2\u2032:4,5]pyrrolo[3,2-c]cinnoline and pyrido[3\u2032,2\u2032:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine: two new ring systems with antitumor activity","volume":"57","author":"Parrino","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib4","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2174\/09298673113206660307","article-title":"Synthesis and antiproliferative activity of substituted 3[2-(1H-indol-3-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[3,2-b]pyridines, marine alkaloid nortopsentin analogues","volume":"21","author":"Carbone","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jhet.5570370413","article-title":"Pyrrolo[3,4-e][1,2,3]triazolo[1,5-a]pyrimidine and pyrrolo[3,4-d][1,2,3]triazolo[1,5-a]pyrimidine. New tricyclic ring systems of biological interest","volume":"37","author":"Lauria","year":"2000","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3253","article-title":"Microtubule-binding agents: a dynamic field of cancer therapeutics","volume":"9","author":"Dumontet","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2016.09.013_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/13543784.2016.1189901","article-title":"Early investigational tubulin inhibitors as novel cancer therapeutics","volume":"25","author":"Nepali","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2016.09.013_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-4939-3542-0_25","article-title":"Anti-microtubule drugs","volume":"1413","author":"Florian","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2016.09.013_bib9","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1038\/sj.onc.1206934","article-title":"Mechanisms of taxol resistance related to microtubules","volume":"22","author":"Orr","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2016.09.013_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: an overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/jpet.115.226225","article-title":"Combretastatins: more than just vascular targeting agents?","volume":"355","author":"Greene","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2016.09.013_bib12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/np0000623","article-title":"Antineoplastic agents 440. Asymmetric synthesis and evaluation of the Combretastatin A-1 SAR probes (1S,2S)- and (1R,2R)1,2-dihydroxy-1-(2\u2032,3\u2032\u2032-dihydroxy-4\u2032-methoxyphenyl)-2-(3\u2032\u2032,4\u2032\u2032,5\u2032\u2032trimehoxyphenyl)ethane","volume":"63","author":"Pettit","year":"2000","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2016.09.013_bib13","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1021\/jm980101w","article-title":"Novel Combretastatin analogues effective against murine solid tumors: design and structure-activity relationships","volume":"41","author":"Ohsumi","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib14","first-page":"981","article-title":"Antineoplastic agents 393. Synthesis of the trans isomer of Combretastatin A-4 prodrug","volume":"13","author":"Pettit","year":"1998","journal-title":"Anti-Cancer Drug Des."},{"key":"10.1016\/j.ejmech.2016.09.013_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: an overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejmech.2013.08.006","article-title":"Synthesis and antiproliferative evaluation of novel benzoimidazole-contained oxazole-bridged analogs of Combretastatin A-4","volume":"68","author":"Zhou","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib17","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1021\/jm500002k","article-title":"Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of Combretastatin-A4 as anticancer agents","volume":"57","author":"Zheng","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib18","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/jm010523x","article-title":"Potent, orally active heterocycle-based Combretastatin A-4 analogues: synthesis, structure-activity relationship, rharmacokinetics, and in\u00a0vivo antitumor activity evaluation","volume":"45","author":"Wang","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0960-894X(01)00759-4","article-title":"Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent","volume":"12","author":"Li","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.09.013_bib20","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.bmc.2005.01.012","article-title":"New naphthylcombretastatins. Modifications on the ethylene bridge","volume":"13","author":"Maya","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib21","first-page":"326523","article-title":"Oxazoline antiproliferative agents, US Patent 6228868","volume":"134","author":"Gwaltney","year":"2001","journal-title":"Chem. Abstr."},{"key":"10.1016\/j.ejmech.2016.09.013_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s002800050795","article-title":"Phase I study of E7010","volume":"42","author":"Yamamoto","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.09.013_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejmech.2015.03.005","article-title":"Water-soluble isoindolo[2,1-a]quinoxalin-6-imines: in\u00a0vitro antiproliferative activity and molecular mechanism(s) of action","volume":"94","author":"Parrino","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib24","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.tet.2013.01.076","article-title":"Synthesis of the new oligopeptide pyrrole derivative isonetropsin and its one pyrrole unit analogue","volume":"69","author":"Montalbano","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.09.013_bib25","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1016\/j.tet.2015.04.083","article-title":"Synthesis of isoindolo[1,4]benzoxazinone and isoindolo[1,5]benzoxazepine: two new ring systems of pharmaceutical interest","volume":"71","author":"Parrino","year":"2015","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.09.013_bib26","doi-asserted-by":"crossref","first-page":"13342","DOI":"10.3390\/molecules190913342","article-title":"Synthesis of the new ring system bispyrido[4',3':4,5]pyrrolo[1,2-a:1',2'-d]pyrazine and its deaza analogue","volume":"19","author":"Parrino","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2016.09.013_bib27","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1016\/j.tet.2014.07.051","article-title":"\u2018Interrupted\u2019 diazotization of 3-aminoindoles and 3-aminopyrroles","volume":"70","author":"Parrino","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.09.013_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejmech.2015.03.009","article-title":"Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity","volume":"94","author":"Parrino","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib29","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/j.tet.2011.03.060","article-title":"Synthesis of the new ring system pyrrolizino[2,3-b]indol-4(5H)-one","volume":"67","author":"Diana","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.09.013_bib30","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1021\/jm010940+","article-title":"Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory antimitotic agents","volume":"44","author":"Mahboobi","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib31","first-page":"3113","article-title":"2-Aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors","volume":"62","author":"Beckers","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2016.09.013_bib32","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1021\/jm900476c","article-title":"Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure\u2212activity relationship studies","volume":"52","author":"Putey","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib33","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/md13041901","article-title":"3-[4-(1H-Indol-3-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines, nortopsentin analogues with antiproliferative activity","volume":"13","author":"Parrino","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2016.09.013_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bmcl.2004.10.072","article-title":"Tubulin-polymerization inhibitors derived from thalidomide","volume":"15","author":"Inatsuki","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.09.013_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2013.10.014","article-title":"Synthesis of a new class of pyrrolo[3,4-h]quinazolines with antimitotic activity","volume":"74","author":"Span\u00f2","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib36","series-title":"Comprehensive Heterocyclic Chemistry III-Isoxazoles","first-page":"365","volume":"vol. 4","author":"Giomi","year":"2008"},{"key":"10.1016\/j.ejmech.2016.09.013_bib37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/acs.jmedchem.5b01522","article-title":"A\u00a0pyrazolo[3,4-d]pyrimidin-4-amine derivative containing an isoxazole moiety is a selective and potent inhibitor of RET gatekeeper mutants","volume":"59","author":"Yoon","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib38","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1021\/jm400842x","article-title":"Novel 1H-pyrrolo[2,3-b]pyridine derivative nortopsentin analogues: synthesis and antitumor activity in peritoneal mesothelioma experimental models","volume":"56","author":"Carbone","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib39","first-page":"203319","article-title":"Isoxazolo-quinazolines as modulators of protein kinase activity","volume":"156","author":"Caldarelli","year":"2012","journal-title":"Chem. Abstr."},{"key":"10.1016\/j.ejmech.2016.09.013_bib40","first-page":"715759","article-title":"Heterocyclyl compounds and uses thereof","volume":"161","author":"Sharma","year":"2014","journal-title":"Chem. Abstr."},{"key":"10.1016\/j.ejmech.2016.09.013_bib41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1021\/jm201301h","article-title":"Identification of novel \u03b14\u03b22-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity","volume":"55","author":"Yu","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/jm1008715","article-title":"Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry","volume":"54","author":"Yermolina","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib43","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1021\/jm060449o","article-title":"Replacement of the metabolically labile methyl esters in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors with isoxazolone, isoxazole, oxazolone, or cyano substituents","volume":"49","author":"Deng","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib44","first-page":"427383","article-title":"Compounds, compositions, and methods for increasing cftr activity","volume":"163","author":"Bastos","year":"2015","journal-title":"Chem. Abstr."},{"key":"10.1016\/j.ejmech.2016.09.013_bib45","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1021\/jm401274b","article-title":"Discovery and characterization of a novel dihydroisoxazole class of \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators","volume":"56","author":"Patel","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib46","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/jm701372r","article-title":"5-tert-Butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs","volume":"51","author":"Velaparthi","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib47","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3987\/COM-03-9877","article-title":"A\u00a0new tetracyclic ring system of biological interest. Indolo[3,2-e][1,2,3]triazolo[1,5-a]pyrimidines through domino reactions of 2-azidoindole","volume":"60","author":"Lauria","year":"2003","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2016.09.013_bib48","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1016\/j.bmc.2010.04.080","article-title":"Synthesis of pyrrolo[3,2-h]quinolinones with good photochemotherapeutic activity and no DNA damage","volume":"18","author":"Barraja","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib49","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/cmdc.201100085","article-title":"Pyrrolo[3,2-h]quinazolines as photochemotherapeutic agents","volume":"6","author":"Barraja","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2016.09.013_bib50","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.tet.2012.04.041","article-title":"An efficient synthesis of pyrrolo[3',2':4,5]thiopyrano[3,2-b]pyridin-2-one: a new ring system of pharmaceutical interest","volume":"68","author":"Barraja","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.09.013_bib51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/md11030643","article-title":"Synthesis and antiproliferative activity of 2,5-bis(3\u2032-indolyl)pyrroles, analogues of the marine alkaloid nortopsentin","volume":"11","author":"Carbone","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2016.09.013_bib52","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1016\/j.bmc.2006.07.061","article-title":"Pyrrolo[2,3-h]quinolinones: a new ring system with potent photoantiproliferative activity","volume":"14","author":"Barraja","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/cmdc.201100027","article-title":"Synthesis of triazenoazaindoles: a new class of triazenes with antitumor activity","volume":"6","author":"Diana","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2016.09.013_bib54","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.bmcl.2009.01.096","article-title":"Pyrano[2,3-e]isoindol-2-ones, new angelicin heteroanalogues","volume":"19","author":"Barraja","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.09.013_bib55","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.bmc.2011.02.023","article-title":"Pyrrolo[3,4-h]quinolinones a new class of photochemotherapeutic agents","volume":"19","author":"Barraja","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib56","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1016\/j.tetlet.2009.07.045","article-title":"Synthesis of the new ring system 6,8-dihydro-5H-pyrrolo[3,4-h]quinazoline","volume":"50","author":"Barraja","year":"2009","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2016.09.013_bib57","doi-asserted-by":"crossref","first-page":"9839","DOI":"10.1016\/j.tet.2013.09.003","article-title":"Convenient synthesis of pyrrolo[3,4-g]indazoles","volume":"69","author":"Span\u00f2","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.09.013_bib58","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1016\/j.tet.2013.05.083","article-title":"Synthesis of [1,2]oxazolo[5,4-e]indazoles as antitumor agents","volume":"69","author":"Barraja","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.09.013_bib59","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/cmdc.201200296","article-title":"Synthesis and antiproliferative activity of the ring system [1,2]oxazolo[4,5-g]indole","volume":"7","author":"Barraja","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2016.09.013_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10593-011-0743-y","article-title":"Special features of 1,3-dipolar cycloaddition of n-methylazomethinylid to nitrobenzazoles","volume":"47","author":"Starosotnikov","year":"2011","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.ejmech.2016.09.013_bib61","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jhet.599","article-title":"1,3-Dipolar cycloaddition of unstabilized N-methyl azomethine ylide to nitrobenzene annelated with azoles","volume":"48","author":"Starosotnikov","year":"2011","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib62","first-page":"453","article-title":"Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma","volume":"29","author":"Zaffaroni","year":"2007","journal-title":"Cell Oncol."},{"key":"10.1016\/j.ejmech.2016.09.013_bib63","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.18632\/oncotarget.3761","article-title":"Anti-tumor activity of selective inhibitors of XPO1\/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin","volume":"6","author":"De Cesare","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2016.09.013_bib64","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1021\/acs.jmedchem.6b00777","article-title":"Preclinical activity of new [1,2]oxazolo[5,4-e]isoindole derivatives in diffuse malignant peritoneal mesothelioma","volume":"59","author":"Span\u00f2","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.013_bib65","doi-asserted-by":"crossref","first-page":"a005942","DOI":"10.1101\/cshperspect.a005942","article-title":"Signaling pathways that regulate cell division","volume":"4","author":"Rhind","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ejmech.2016.09.013_bib66","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1158\/1535-7163.MCT-05-0022","article-title":"Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation","volume":"4","author":"Pennati","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2016.09.013_bib67","first-page":"130","article-title":"Raf-1\/bcl-2 phosphorylation: a step from microtubule damage to cell death","volume":"57","author":"Blagosklonny","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2016.09.013_bib68","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1158\/1535-7163.MCT-09-0798","article-title":"Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity","volume":"8","author":"Appierto","year":"2009","journal-title":"Mol. Cancer Ther."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416307395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416307395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T16:25:08Z","timestamp":1536423908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416307395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":68,"alternative-id":["S0223523416307395"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.09.013","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[1,2]Oxazolo[5,4-e]isoindoles as promising tubulin polymerization inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}